4453 Total Publications
Genome-wide pathway analysis of memory impairment in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks
Ramanan, V. K., Kim, S., Holohan, K., Shen, L., Nho, K., Risacher, S. L., … Saykin, A. J.
PMID: 22865056
;
PMCID:3713637
; 2012; Journal Brain Imaging and Behaviour; vol. 6; pp. 634-648;
doi:10.1007/s11682-012-9196-x
Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease
Gray, K. R., Wolz, R., Heckemann, R. a, Aljabar, P., Hammers, A., & Rueckert, D.
PMID: 22236449
;
PMCID:3303084
; 2012; Journal Neuroimage; vol. 60; no. 1; pp. 221-229;
doi:10.1016/j.neuroimage.2011.12.071
Confirmatory Factor Analysis of the Spectator Decision-Making Inventory (SDMI)
Park, L. Q., Gross, A. L., McLaren, D. G., Pa, J., Johnson, J. K., Mitchell, M., & Manly, J. J.
PMID: 22777078
;
PMCID:3538867
; 2012; Journal Brain Imaging and Behaviour; vol. 6; no. 4; pp. 528-39;
doi:10.1007/s11682-012-9190-3
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer’s disease
Cruchaga, C., Kauwe, J. S. K., Nowotny, P., Bales, K., Pickering, E. H., Mayo, K., … Goate, A. M.
PMID: 22821396
;
PMCID:3459471
; 2012; Journal Human Molecular Genetics; vol. 21; no. 20; pp. 4558-71;
doi:10.1093/hmg/dds296
CSF Biomarker and PIB-PET–Derived Beta-Amyloid Signature Predicts Metabolic, Gray Matter, and Cognitive Changes in Nondemented Subjects
Ewers, M., Insel, P., Jagust, W. J., Shaw, L., Trojanowski J, J. Q., Aisen, P., … Weiner, M. W.
PMID: 22038908
;
PMCID:3500862
; 2012; Journal Cerebral Cortex; vol. 22; no. 9; pp. 1993-2004;
doi:10.1093/cercor/bhr271
Plasma biomarkers of depressive symptoms in older adults
Arnold, S. E., Xie, S. X., Leung, Y.-Y., Wang, L.-S., Kling, M. a, Han, X., … Shaw, L. M.
PMID: 22832727
; 2012; Journal Translational Psychiatry; vol. 2; no. 1; pp. e65;
doi:10.1038/tp.2011.63